HOB Biotech Group Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020
April 14, 2021 at 06:14 am
Share
HOB Biotech Group Corp. Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 221.856 million compared to CNY 259.127 million a year ago. Operating income was CNY 65.099 million compared to CNY 70.053 million a year ago. Net income was CNY 56.617 million compared to CNY 63.838 million a year ago. Basic earnings per share from continuing operations was CNY 1.2 compared to CNY 1.35 a year ago.
HOB Biotech Group Corp Ltd is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic reagents. The Company provides two categories of products: allergy testing products and self-immune testing products. Its detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. It is also engaged in the provision of reagent supporting testing instruments and others. The Company conducts its businesses in the domestic market.